Short pages

Jump to navigation Jump to search

Showing below up to 50 results in range #87,091 to #87,140.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Mastalgia medical therapy [3,512 bytes]
  2. (hist) Growth hormone 1 [3,512 bytes]
  3. (hist) Popliteal artery [3,513 bytes]
  4. (hist) Hemopure [3,513 bytes]
  5. (hist) Kepone [3,513 bytes]
  6. (hist) CMA-ES [3,513 bytes]
  7. (hist) D'Agostino's K-squared test [3,513 bytes]
  8. (hist) Positivity/negativity ratio [3,513 bytes]
  9. (hist) Metabolic acidosis (patient information) [3,513 bytes]
  10. (hist) Tachypnea causes [3,513 bytes]
  11. (hist) Gonorrhea screening [3,513 bytes]
  12. (hist) Nutcracker esophagus medical therapy [3,513 bytes]
  13. (hist) Piperacillin tazobactam sodium description [3,513 bytes]
  14. (hist) RNF220 [3,513 bytes]
  15. (hist) Malonyl-CoA decarboxylase deficiency [3,514 bytes]
  16. (hist) Z curve [3,514 bytes]
  17. (hist) Allicin [3,514 bytes]
  18. (hist) Protein-glutamate O-methyltransferase [3,514 bytes]
  19. (hist) Exercise-induced anaphylaxis [3,514 bytes]
  20. (hist) Template to add a clinical trial [3,514 bytes]
  21. (hist) Template to add a clinical trial copy [3,514 bytes]
  22. (hist) Azithromycin And Coronary Events Study In Patients With Stable Coronary Disease [3,514 bytes]
  23. (hist) Oral cancer causes [3,514 bytes]
  24. (hist) Addison's disease history and symptoms [3,514 bytes]
  25. (hist) Alcoholic cardiomyopathy echocardiography [3,514 bytes]
  26. (hist) Azelastine (patient information) [3,514 bytes]
  27. (hist) Multiple endocrine neoplasia type 2 (patient information) [3,514 bytes]
  28. (hist) Adenoiditis medical therapy [3,514 bytes]
  29. (hist) WDR24 [3,514 bytes]
  30. (hist) CTA-126B4.3 [3,514 bytes]
  31. (hist) Humidifier Lung [3,515 bytes]
  32. (hist) New Guinea Lung [3,515 bytes]
  33. (hist) Hypersensitivity Vasculitis [3,515 bytes]
  34. (hist) Hamartomas [3,515 bytes]
  35. (hist) Hypothalamic-Adrenal Dysfunction [3,515 bytes]
  36. (hist) Hypokalemic Nephropathy [3,515 bytes]
  37. (hist) Iodide-induced Hyperthyroidism [3,515 bytes]
  38. (hist) Neonatal Thyrotoxicosis [3,515 bytes]
  39. (hist) Nontumorigenic Pituitary-Induced Hyperthyroidism [3,515 bytes]
  40. (hist) Mixed Gonadal Dysgenesis [3,515 bytes]
  41. (hist) Hand-Schuller-Christian Disease [3,515 bytes]
  42. (hist) Cytarabine (patient information) [3,515 bytes]
  43. (hist) Group Analysis [3,515 bytes]
  44. (hist) Study proposes a final common pathway linking smoking, kidney disease, and inflammation to atherogenesis [3,515 bytes]
  45. (hist) Grading (tumors) [3,515 bytes]
  46. (hist) The Living Guidelines: STEMI Thienopyridines Suggest Revisions to the CLASS IIa Guidelines [3,515 bytes]
  47. (hist) Orlistat pharmacokinetics and molecular data [3,515 bytes]
  48. (hist) The Living Guidelines: Patients with Reduced LVEF. Suggest Revisions to the CLASS IIb Guidelines [3,515 bytes]
  49. (hist) Raltegravir drug interactions [3,515 bytes]
  50. (hist) Autoimmune retinopathy medical therapy [3,515 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)